Persistent Weight Maintenance for 6 Months After 3 Months of Active Weight Loss

November 1, 2019 updated by: Ji-Won Lee, Gangnam Severance Hospital

An Observation Study on Maintaining Weight for 6 Months After 3 Months of Weight Loss Program

This study is intended to report changes in the weight and metabolic indicators of the subjects six months after the end of the study for adults with a risk factor of 27 kg/m2 or higher (formerly the research task name[clinicaltrial.gov;NCT03675191]).

Study Overview

Status

Unknown

Conditions

Detailed Description

There was no special intervention after the previous research intervention. After the previous research was completed, we will check the changes in the body composition and metabolic indicators over six months.

Study Type

Observational

Enrollment (Anticipated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Yu-Jin Kwon, Dr
  • Phone Number: 031-331-8710
  • Email: digda3@yuhs.ac

Study Locations

    • Gyeonggi-do
      • Yongin, Gyeonggi-do, Korea, Republic of, 17046
        • Recruiting
        • Yongin Severance Hospital
        • Contact:
          • Yu-Jin Kwon, Dr

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Body mass index (BMI) more than 27kg/m2 with comorbidities or BMI more than 30kg/m2

Description

Inclusion Criteria:

  • Those who have participated in the previous trial (NCT03675191) and have completed the three-month study
  • Those who agreed the trial.

Exclusion Criteria:

  • Those who have withdrawn the previous trial (NCT03675191)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
overweight or obese adults
overweight or obese adults who participate the trial (NCT03675191)

This study is an observational study for 96 people who have completed the previous weight loss program.

We will check the body composition and lipid profile of the participants who voluntarily visit after 6months after the end of the study. .

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
weight
Time Frame: after 6months
weight changes
after 6months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
lipid profile
Time Frame: after 6months
total cholesterol, LDL cholesterol, HDL cholesterol, triglyceride
after 6months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yu-Jin Kwon, Dr, Severance Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 17, 2019

Primary Completion (Anticipated)

October 30, 2019

Study Completion (Anticipated)

November 30, 2019

Study Registration Dates

First Submitted

October 31, 2019

First Submitted That Met QC Criteria

November 1, 2019

First Posted (Actual)

November 4, 2019

Study Record Updates

Last Update Posted (Actual)

November 4, 2019

Last Update Submitted That Met QC Criteria

November 1, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • YI201905

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Weight Reduction

Clinical Trials on observation of weight after 6months

3
Subscribe